Impact and Control of Drug Therapy Guidelines for Tumor Patients During the Novel Coronavirus Pneumonia Epidemic
- 1 Universiti Kuala Lumpur, Malaysia
- 2 The Millennium University, Pakistan
Since December 2019, many unexplained viral pneumonia cases have been found in Wuhan City, Hubei Province, China. It was later confirmed that the outbreak's causative agent was a new coronavirus. The virus was temporarily named "2019-new coronavirus" (2019-nCoV) by the World Health Organization (WHO). The diseases caused by 2019-nCoV were called by the National Health and Health Commission of China "New coronavirus pneumonia" (Novel Coronavirus Pneumonia, NCP) and was named "Coronavirus disease 2019" (COVID-19) by the WHO. The outbreak of NCP seriously affected the lives of the public. This article focuses on the group of cancer patients, comprehensively considers the social, medical resources and family issues to analyze the possible impact of the epidemic on cancer patients' drug treatment and health and makes recommendations for cancer patients' management.
Copyright: © 2021 Razi Ahmed, Shafiza Mohd Shariff, Shahrinaz Ismail, Anwer Irshad Burney and Nawaf Waqas. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- 179 Views
- 106 Downloads
- 0 Citations
- Pneumonia and Healthcare